Trial intelligence / Profile preview

Continuation versus discontinuation of antiarrhythmic drugs before pulmonary vein isolation in atrial fibrillation

NL-OMON29546Active, not recruiting

Sponsor
Medisch Spectrum Twente
Start
Nov 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of adenosine in Atrial fibrillation (AFib) (2 arms), sponsored by Medisch Spectrum Twente. Started Nov 2015; status: active, not recruiting.

02

Drugs

adenosine
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NL-OMON29546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON29546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call